Mechanisms of Allostery and Molecular Recognition in the Small Multidrug Resistan

小型多药耐药性的变构和分子识别机制

基本信息

批准号：
8882245
负责人：
Nathaniel J. Traaseth
金额：
$ 38.88万
依托单位：
NEW YORK UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-07-15 至 2019-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8882245
关键词：
Abbreviations Active Biological Transport Address Animals Antibiotic Resistance Antibiotics Architecture Bacteria Binding Biochemical Biocide Cations Cells Chemicals Clinical Clinics and Hospitals Coupled Coupling Drug Efflux Drug toxicity Electronics Environment Erythromycin Exhibits Family Foundations Goals Health Homologous Gene Human Hybrids Infection Ions Ligands Lipids Local Anti-Infective Agents Magic Membrane Membrane Lipids Modeling Molecular Molecular Conformation Molecular Motors Molecular Structure Multi-Drug Resistance Mutation NMR Spectroscopy Nature Organism P-Glycoproteins Pattern Pharmaceutical Preparations Protein Family Proteins Proton-Motive Force Research Research Project Grants Resistance Resistance profile Resolution Role Shapes Side Site Solutions Specificity Structure Superbug Testing Transport Process antiport base biophysical analysis combat conformational conversion design efflux pump flexibility inhibitor/antagonist insight macromolecular assembly molecular recognition multi drug transporter mutant novel therapeutics pathogen research study resistance mechanism scaffold solid state nuclear magnetic resonance structural biology trait

项目摘要

DESCRIPTION (provided by applicant): The goal of this proposal is to characterize the mechanisms of allostery and drug recognition within the small multidrug resistance (SMR) protein family. Multidrug resistance (MDR) to antibiotics is the ability of bacteria to confer simultaneous resistance to a wide variety of chemically distinct molecules. While several new antibiotics exhibiting different chemical scaffolds have been successfully developed and modified, MDR remains a pervasive problem in hospitals and clinics. We will reveal the allosteric control mechanism and molecular interactions at the atomic level that enable SMR proteins to recognize a wide variety of drugs. These molecular motors require energy dependent conformational transitions and protein-protein macromolecular assemblies to carry out function. Our high-resolution structural biology approach will employ NMR spectroscopy to reveal the details at the molecular level. While biochemical and biophysical studies have laid the foundation for this research, the molecular mechanism by which these proteins recognize drugs, become activated, and subsequently confer resistance is unknown. Our studies will provide a structural dynamics-function correlation for providing insight into this significant human health problem, and in doing so will reveal a molecular picture of the MDR phenomenon from the standpoint of the SMR family that can be applied to other families in order to better understand clinical resistance.

描述（由申请人提供）：该提案的目标是表征小型多药耐药（SMR）蛋白家族内的变构和药物识别机制。对抗生素的多药耐药性（MDR）是指细菌同时对多种化学上不同的分子产生耐药性的能力。尽管已经成功开发和改进了几种具有不同化学支架的新型抗生素，但耐多药仍然是医院和诊所中普遍存在的问题。我们将揭示原子水平上的变构控制机制和分子相互作用，使 SMR 蛋白能够识别多种药物。这些分子马达需要能量依赖的构象转变和蛋白质-蛋白质大分子组装来执行功能。我们的高分辨率结构生物学方法将采用核磁共振波谱来揭示分子水平的细节。虽然生化和生物物理学研究为这项研究奠定了基础，但这些蛋白质识别药物、被激活并随后赋予耐药性的分子机制尚不清楚。我们的研究将提供结构动力学-功能相关性，以深入了解这一重大的人类健康问题，从而从 SMR 家族的角度揭示 MDR 现象的分子图景，该图景可应用于其他家族，以便更好地了解临床耐药性。